This webinar has been commissioned by Pfizer Ltd on behalf of the BMS – Pfizer Alliance and organised in conjunction with Guidelines. See bottom of page for full disclaimer.

white:blue BMS pfizer logo

 Free webinar: Tuesday 9 July 2019, 13.30–14.30 

20190514 Pfizer webinar cover image v2

The purpose of this Guidelines webinar is to:

  • describe the recognition and referral of patients presenting with pulmonary embolism (PE) in primary care
  • discuss guidance relevant to the acute phase of treatment and the therapeutic regimens prescribed in secondary care in this period
  • clarify which patients should receive long-term treatment and what this consists of, with reference to relevant guidance and medication choice.

Watch presentations from expert speakers:

Nigel Rowell

Dr Nigel Rowell

Retired GP, Endeavour Practice, Middlesbrough; former Cardiovascular Lead for the North of England, National Service Improvement Lead for Heart Failure, and NHS Clinical Champion for Atrial Fibrillation

Colin Church image

 

Dr Colin Church

Consultant in Pulmonary, Vascular, and Respiratory Medicine, Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow

 

Earn_1_cpd_

 

 

 

 

Click here to register for the webinar

To contact Pfizer Ltd for any other purpose, please call 01304 616161. Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.

This webinar has been commissioned by Pfizer Ltd on behalf of the BMS – Pfizer Alliance, and organised in conjunction with Guidelines. Pfizer Ltd has reviewed the scope of the webinar, chosen and commissioned the speakers, and approved all materials related to the webinar. Pfizer Ltd has paid the speaker honoraria. The views and opinions of the speakers are not necessarily those of Pfizer Ltd, Guidelines, its publisher, advisers, or advertisers.

PP-ELI-GBR-5032

Date of preparation: April 2019